Interleukin-10 and Small Molecule SHIP1 Allosteric Regulators Trigger Anti-inflammatory Effects through SHIP1/STAT3...

Area of Science:

• Immunology
• Molecular Biology
• Pharmacology

Background:

• Interleukin-10 (IL10) exerts anti-inflammatory effects, primarily through STAT3.
• Pro-inflammatory cytokines like Interleukin-6 (IL6) also utilize STAT3 signaling pathways.
• The precise molecular mechanisms of IL10's anti-inflammatory actions require further elucidation.

Purpose of the Study:

• To investigate the molecular complex formation induced by IL10 signaling.
• To explore the role of inositol polyphosphate-5-phosphatase (SHIP1) in IL10-mediated anti-inflammatory responses.
• To evaluate the therapeutic potential of SHIP1-activating compounds.

Main Methods:

• Macrophage cell cultures stimulated with IL10 and IL6.
• Co-immunoprecipitation to detect protein complex formation.
• Nuclear translocation assays for SHIP1 and STAT3.
• In vivo studies using a mouse model of colitis.
• Crystallography and molecular docking for drug-binding pocket identification.

Main Results:

• IL10 signaling specifically induces a SHIP1/STAT3 complex in macrophages, unlike IL6.
• Both SHIP1 and STAT3 translocate to the nucleus following IL10 stimulation.
• Pelorol sesquiterpenes, SHIP1 activators, promote SHIP1/STAT3 complex formation and exhibit anti-inflammatory effects in a colitis model.
• A drug-binding pocket within SHIP1 was identified through structural studies.

Conclusions:

• IL10's anti-inflammatory action involves the formation of a SHIP1/STAT3 complex in macrophages.
• SHIP1 and STAT3 nuclear translocation is crucial for IL10's signaling pathway.
• Allosteric SHIP1 activators represent a promising therapeutic strategy for inflammatory diseases by mimicking IL10's beneficial effects.